South Africa's national response to HIV and AIDS treatment: Popular media's perspective

Croatian Medical Journal

Volumn 49, Issue 1, 2008, Pages 114-119

  Muula, Adamson S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; HEALTH PRACTITIONER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; MASS MEDIUM; MORBIDITY; OPPORTUNISTIC INFECTION; PAPANICOLAOU TEST; SOUTH AFRICA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEALTH POLICY; HIV INFECTIONS; HUMANS; MASS MEDIA; PERCEPTION; PUBLIC HEALTH; SOUTH AFRICA;

EID: 40449119217     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2008.1.114     Document Type: Letter

References (36)

1. UNAIDS. AIDS epidemic update. UNAIDS: Geneva (Switzerland); 2007.
2. Louwagie GM, Bachmann MO, Meyer K, Booysen Fle R, Fairall LR, Heunis C. Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health. 2007;7:244. Medline:17854510 doi:10.1186/1471-2458-7-244
3. Taylor K, DeYoung P. WHO's 3-by-5 target. Lancet. 2003;362:918. Medline:13678988 doi:10.1016/S0140-6736(03)14314-0
4. Muula AS. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals. Croat Med J. 2004;45:415-21.
5. Bateman C. KZN Global AIDS Fund bid 'non-negotiable'. S Afr Med J. 2002;92:848-9.
6. Nattrass N. South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment. J Acquir Immune Defic Syndr. 2006;43:618-23.
7. Parkhurst JO, Lush L. The political environment of HIV: lessons from a comparison of Uganda and South Africa. Soc Sci Med. 2004;59:1913-24. Medline:15312925 doi:10.1016/j.socscimed.2004.02.026
8. Deghaye N, Pawinski RA, Desmond C. Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal. S Afr Med J. 2006;96:140-3.
9. Nattrass N. AIDS denialism vs. science. Skeptical Inquirer. 2007;31:31-7.
10. Wines M. Official in furor on AIDS policy in South Africa is hospitalized. New York Times. 2007 Feb 23. Available from: http://www. nytimes.com/2007/02/23/world/africa/23africa.html?ex=1329886800&en= 69c46ce246b46d7e&ei=5088&partner=rssnyt&emc=rss. Accessed: February 8, 2008.
11. Wine M. Under fire, South Africa shakes up its strategy against AIDS. New York Times. 2006 Nov 3. Available from: http://www.nytimes.com/2006/11/03/ world/africa/03safrica.html. Accessed: February 8, 2008.
12. Cohen J. HIV/AIDS. AIDSTruth. org Web site takes aim at 'denialists'. Science. 2007;316:1554. Medline:17569834 doi:10.1126/science.316.5831.1554
13. Washington HA. Africa fears western medicine. The International Herald Tribune. 2007 Aug 17. Available from: http://yaleglobal.yale.edu/display. article?id=9547. Accessed: February 8, 2008.
14. News BBC. The UN's rebel advocate on AIDS. Available from: http://news.bbc.co.uk/2/hi/health/6059206.stm. Accessed: February 8, 2008.
15. Watson J. Scientist, activists sue South Africa's AIDS 'denialists'. Nat Med. 2006;12:6. Medline:16397537 doi:10.1038/nm0106-6a
16. McCoy D, Chopra M, Loewenson R, Aitken JM, Ngulube T, Muula A, et al. Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health. 2005;95:18-22. Medline:15623853 doi:10.2105/AJPH.2004.040121
17. Akukwe A. South Africa's leadership on HIV/AIDS is a welcome development. Available from: http://www.worldpress.org/Africa/2826.cfm. Accessed: February 8, 2008.
18. Achmat Z, Simcock J. Combining prevention, treatment and care: lessons from South Africa. AIDS. 2007;21 Suppl 4:S11-20. Medline:17620746 doi:10.1097/01.aids.0000279702.71062.52
19. Harling G, Bekker LG, Wood R. Cost of a dedicated ART clinic. S Afr Med J. 2007;97:593-6.
20. Johnson LF, McLeod HD. Steady growth in antiretroviral treatment provision by disease management and community treatment programmes. S Afr Med J. 2007;97:358-9.
21. Republic of South Africa. Operational plan for comprehensive HIV and AIDS Care and Treatment, 2003. Available from: http://www.info.gov.za/otherdocs/ 2003/aidsplan/annexes.pdf. Accessed: February 8, 2008.
22. South African Medical Association Statements by South African Medical Association on Matthias Rath. SAMA notes resurgence of unfounded therapies for HIV/AIDS. Available from: http://www.tac.org.za/newsletter/2005/ns23_03_2005. htm. Accessed: February 8, 2008.
23. Southern Africa AIDS Clinicians Society. Statement by the Southern African HIV Clinicans Society on Matthias Rath, 2005. Available from: http://www.tac.org.za/newsletter/2005/ns23_03_2005.htm. Accessed: February 8, 2008.
24. Cullinan K. South Africa takes first steps to provide antiretrovirals. Bull World Health Organ. 2002;80:921.
25. Chopra M, Kendall C, Hill Z, Schaay N, Nkonki LL, Doherty TM. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa. AIDS. 2006;20:1975-7. Medline:16988520 doi:10.1097/01.aids. 0000247120.12327.6b
26. Day JH, Miyamura K, Grant AD, Leeuw A, Munsamy J, Baggaley R, et al. Attitudes to HIV voluntary counselling and testing among mineworkers in South Africa: will availability of antiretroviral therapy encourage testing? AIDS Care. 2003;15:665-72. Medline:12959817 doi:10.1080/0954012030001595140
27. Ahimbisiwe F. Museveni cautions youth on circumcision. The New Vision. 2008 Nov 7. Available from: http://www.newvision.co.ug/D/8/13/596096. Accessed: February 8, 2008.
28. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298. Medline:16231970 doi:10.1371/journal.pmed.0020298
29. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643-56. Medline:17321310 doi:10.1016/S0140- 6736(07)60312-2
30. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657-66. Medline:17321311 doi:10.1016/S0140-6736(07) 60313-4
31. News BBC. Ugandan men getting circumcision. Available from: http://news.bbc.co.uk/2/hi/africa/6227533.stm. Accessed: February 8, 2008.
32. International Planned Parenthood Federation. Uganda: circumcision should not be used as HIV prevention method. Available from: http://www.ippf.org/NR/ exeres/24B0E8BCBFA1-4526-9A41-42863BB93FBF.htm. Accessed: February 8, 2008.
33. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, et al. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health. 2007;7:63. Medline:17459154 doi:10.1186/1471-2458-7-63
34. Liu J. The use of herbal medicines in early drug development for the treatment of HIV infections and AIDS. Expert Opin Investig Drugs. 2007;16:1355-64. Medline:17714022 doi:10.1517/13543784.16.9.1355
35. Suttajit M. Advances in nutrition support for quality of life in HIV+/AIDS. Asia Pac J Clin Nutr. 2007;16:318-22.
36. Miles N. South Africa's broken HIV promises. Avaialble from: http://news.bbc.co.uk/2/hi/africa/4482007.stm. Accessed: February 8, 2008.